You are now leaving lundbeck.com/au. Please note that the information contained in the site you are linking to may not be fully compliant with the Australian regulatory environment and that product related information should be checked against the corresponding Australian consumer medicine information or by asking your doctor. Any information provided should be discussed with your health care professional and does not replace the advice and treatment of your doctor.
Lundbeck was founded by Hans Lundbeck in Copenhagen more than 100 years ago.
We are approximately 5,800 employees worldwide.
Our largest shareholder is the Lundbeck Foundation owning approximately 70%.
Our products are registered in more than 100 countries globally.
Number of years that we have been building our neuroscience expertise.
Our portfolio of products reaches more than 50 million people yearly.
We are headquartered in Denmark and located in more than 50 countries around the world. We have production facilities in Denmark, France and Italy and research centers in Denmark and US.
We have employees in more than 50 countries and employ approximately 5,800 people across the value chain.
In 1999, Lundbeck’s shares were listed on Nasdaq Copenhagen. Our largest shareholder is the Lundbeck Foundation, which holds approximately 70% of the shares. The Foundation annually grants about DKK 500 million to support medical research and educational and communication activities.
Our 2019 revenue reached a total of DKK 17,036 million.
Our largest markets are US, China, Canada, Spain, Italy, France, Japan, Korea, Australia and Brazil.
In 2019, our total revenue from strategic brands was DKK 9,385 million.